إعلان
إعلان

AORT

AORT logo

Artivion, Inc.

44.33
USD
برعاية
-0.52
-1.15%
٠٩ يناير, ١٠:٠٨ UTC -5
مفتوح

تقارير أرباح AORT

النسبة الإيجابية المفاجئة

AORT تفوق 27 من 39 آخر التقديرات.

69%

التقرير التالي

بيانات التقرير القادم
٢٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$118.75M
/
$0.08
التغير الضمني من Q3 25 (Revenue/ EPS)
+6.61%
/
+33.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
+22.03%
/
-120.51%

Artivion, Inc. earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, AORT reported earnings of 0.06 USD per share (EPS) for Q3 25, beating the estimate of 0.01 USD, resulting in a 242.86% surprise. Revenue reached 111.39 مليون, compared to an expected 112.65 مليون, with a -1.12% difference. The market reacted with a -5.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 المحللين forecast an EPS of 0.08 USD, with revenue projected to reach 118.75 مليون USD, implying an زيادة of 33.33% EPS, and زيادة of 6.61% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
٠٦ يناير ٢٠٢٦ إلى ربع سنوي2 26
تقدير
-$0.10
الفعلي
$0.00
مفاجئة
+100.00%
الأسئلة الشائعة
For Q3 2025, Artivion, Inc. reported EPS of $0.06, beating estimates by 242.86%, and revenue of $111.39M, -1.12% below expectations.
The stock price moved down -5.54%, changed from $47.50 before the earnings release to $44.87 the day after.
The next earning report is scheduled for ٢٣ فبراير ٢٠٢٦.
Based on 9 المحللين, Artivion, Inc. is expected to report EPS of $0.08 and revenue of $118.75M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان